PHILADELPHIA

费城

,

，

April 16, 2026

2026年4月16日

/PRNewswire/ --

/PRNewswire/ --

Signant Health

签名健康

, the evidence generation company, today announced that it has entered into a definitive agreement to acquire

，证据生成公司，今天宣布已达成最终协议收购

Ametris

阿米特里斯

(formerly ActiGraph), a global digital health solutions provider, subject to customary regulatory processes and approvals and closing conditions. More details about the transaction and combined offering will be shared upon completion of the acquisition.

（前身为ActiGraph）是一家全球数字健康解决方案提供商，需遵循惯例的监管流程、审批及交割条件。关于本次交易和整合服务的更多细节将在收购完成后分享。

About Signant Health

关于Signant Health

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics.

Signant Health 是一家证据生成公司。我们专注于利用软件、深厚的治疗和科学知识以及运营专业知识，持续捕捉、汇总并揭示传统、虚拟和混合试验模型中临床研究的高质量证据。在过去的 25 年里，超过 600 家各种规模的申办方和合同研究组织（CRO）——包括全球前 20 大制药公司——都信赖 Signant 的解决方案，涵盖远程和现场的电子临床结果评估（eCOA）、电子数据采集（EDC）、电子知情同意（eConsent）、随机化与试验供应管理（RTSM）、供应链管理以及数据质量分析。

Learn more at .

了解更多，请访问。

www.signanthealth.com

www.signanthealth.com

Contact:

联系人：

Heather Bilinski

贺瑟·比利恩斯基

[email protected]

电子邮件地址

+1 610.400.4141

+1 610.400.4141

SOURCE Signant Health

来源 Signant Health

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示